WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
This Quarter Return
+19.54%
1 Year Return
-17.41%
3 Year Return
-27.69%
5 Year Return
+67.02%
10 Year Return
–
AUM
$1.26B
AUM Growth
+$1.26B
(+52%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
23.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
6
Reduced
1
Closed
1
Top Buys
| 1 |
AUTL
Autolus Therapeutics
AUTL
|
$283M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$71.5M |
| 3 |
Theravance Biopharma
TBPH
|
$15.7M |
| 4 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
$7.52M |
| 5 |
Biogen
BIIB
|
$5.3M |
Top Sells
| 1 |
Alkermes
ALKS
|
$87.3M |
| 2 |
Altria Group
MO
|
$6.7M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Theravance Biopharma
TBPH
$699M
| $382M | 30.43% | 11,694,879 +481,000 | +4% | +$15.7M |
|
|
AUTL
2
Autolus Therapeutics
AUTL
$399M
| $332M | 26.44% | 10,825,919 +9,234,176 | +580% | +$283M |
|
3
Prothena Corp
PRTA
$441M
| $156M | 12.42% | 11,924,614 | – | – |
|
|
4
Alkermes
ALKS
$4.78B
| $113M | 8.99% | 2,659,676 -2,057,334 | -44% | -$87.3M |
|
|
5
Biogen
BIIB
$19.4B
| $104M | 8.29% | 294,564 +15,000 | +5% | +$5.3M |
|
|
6
Agios Pharmaceuticals
AGIO
$2.19B
| $102M | 8.09% | 1,317,459 +927,459 | +238% | +$71.5M |
|
|
EVFM
7
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $38.9M | 3.09% | 9,593,197 | – | – |
|
|
NCNA
8
NuCana
NCNA
$6.09M
| $14.3M | 1.14% | 572,000 +152,000 | +36% | +$3.79M |
|
|
NITE
9
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $13.9M | 1.11% | 682,109 +368,109 | +117% | +$7.52M |
|
|
10
Altria Group
MO
$113B
| – | – | -118,000 | Closed | -$6.7M |
|